Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.

dc.contributor.author

Eapen, Zubin J

dc.contributor.author

Hammill, Bradley G

dc.contributor.author

Setoguchi, Soko

dc.contributor.author

Schulman, Kevin A

dc.contributor.author

Peterson, Eric D

dc.contributor.author

Hernandez, Adrian F

dc.contributor.author

Curtis, Lesley H

dc.coverage.spatial

England

dc.date.accessioned

2017-07-06T15:59:02Z

dc.date.available

2017-07-06T15:59:02Z

dc.date.issued

2013-09-11

dc.description.abstract

BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. CONCLUSIONS: Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/24025363

dc.identifier

jah3301

dc.identifier.eissn

2047-9980

dc.identifier.uri

https://hdl.handle.net/10161/15016

dc.language

eng

dc.publisher

Ovid Technologies (Wolters Kluwer Health)

dc.relation.ispartof

J Am Heart Assoc

dc.relation.isversionof

10.1161/JAHA.113.000242

dc.subject

Medicare Part D

dc.subject

heart failure

dc.subject

outcome assessment (health care)

dc.subject

Aged, 80 and over

dc.subject

Drug Utilization

dc.subject

Female

dc.subject

Heart Failure

dc.subject

Humans

dc.subject

Male

dc.subject

Medicare Part D

dc.subject

Prescription Drugs

dc.subject

United States

dc.title

Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.

dc.type

Journal article

duke.contributor.orcid

Hammill, Bradley G|0000-0002-0389-6434

duke.contributor.orcid

Peterson, Eric D|0000-0002-5415-4721

duke.contributor.orcid

Hernandez, Adrian F|0000-0003-3387-9616

duke.contributor.orcid

Curtis, Lesley H|0000-0002-3286-9371

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/24025363

pubs.begin-page

e000242

pubs.issue

5

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Faculty

pubs.organisational-group

Initiatives

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Cardiology

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

School of Medicine

pubs.publication-status

Published online

pubs.volume

2

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.pdf
Size:
263.79 KB
Format:
Adobe Portable Document Format